ARTICLE | Clinical News
Diamyd: Phase II start
February 4, 2013 8:00 AM UTC
This month, Diamyd said that Linkoping University will begin the 30-month, double-blind, Swedish Phase II DIABGAD-1 trial to evaluate Diamyd in 60 Type I diabetics ages 10-18 years. Patients will rece...